Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism. (14th November 2013)
- Record Type:
- Journal Article
- Title:
- Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism. (14th November 2013)
- Main Title:
- Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism
- Authors:
- Huang, Mei
Panos, John J.
Kwon, Sunoh
Oyamada, Yoshihiro
Rajagopal, Lakshmi
Meltzer, Herbert Y. - Abstract:
- <abstract abstract-type="main" id="jnc12512-abs-0001"> <title>Abstract</title> <p>Atypical antipsychotic drugs (AAPDs) have been suggested to be more effective in improving cognitive impairment in schizophrenia than typical APDs, a conclusion supported by differences in receptor affinities and neurotransmitter efflux in the cortex and the hippocampus. More potent serotonin (5‐HT)<sub>2A</sub> than dopamine (DA) D<sub>2</sub> receptors antagonism, and direct or indirect 5‐HT<sub>1A</sub> agonism, characterize almost all AAPDs. Blonanserin, an AAPD, has slightly greater affinity for D<sub>2</sub> than 5‐HT<sub>2A</sub> receptors. Using microdialysis and ultra performance liquid chromatography‐mass spectrometry/mass spectrometry, we compared the abilities of the typical APD, haloperidol, three AAPDs, blonanserin, lurasidone, and olanzapine, and a selective 5‐HT<sub>1A</sub> partial agonist, tandospirone, and all, except haloperidol, were found to ameliorate the cognitive deficits produced by the <italic>N</italic>‐methyl‐d‐aspartate antagonist, phencyclidine, altering the efflux of neurotransmitters and metabolites in the rat cortex and nucleus accumbens. Blonanserin, lurasidone, olanzapine, and tandospirone, but not haloperidol, increased the efflux of cortical DA and its metabolites, homovanillic acid and 3, 4‐dihydroxyphenylacetic acid. Olanzapine and lurasidone increased the efflux of acetylcholine; lurasidone increased glutamate as well. None of the compounds significantly<abstract abstract-type="main" id="jnc12512-abs-0001"> <title>Abstract</title> <p>Atypical antipsychotic drugs (AAPDs) have been suggested to be more effective in improving cognitive impairment in schizophrenia than typical APDs, a conclusion supported by differences in receptor affinities and neurotransmitter efflux in the cortex and the hippocampus. More potent serotonin (5‐HT)<sub>2A</sub> than dopamine (DA) D<sub>2</sub> receptors antagonism, and direct or indirect 5‐HT<sub>1A</sub> agonism, characterize almost all AAPDs. Blonanserin, an AAPD, has slightly greater affinity for D<sub>2</sub> than 5‐HT<sub>2A</sub> receptors. Using microdialysis and ultra performance liquid chromatography‐mass spectrometry/mass spectrometry, we compared the abilities of the typical APD, haloperidol, three AAPDs, blonanserin, lurasidone, and olanzapine, and a selective 5‐HT<sub>1A</sub> partial agonist, tandospirone, and all, except haloperidol, were found to ameliorate the cognitive deficits produced by the <italic>N</italic>‐methyl‐d‐aspartate antagonist, phencyclidine, altering the efflux of neurotransmitters and metabolites in the rat cortex and nucleus accumbens. Blonanserin, lurasidone, olanzapine, and tandospirone, but not haloperidol, increased the efflux of cortical DA and its metabolites, homovanillic acid and 3, 4‐dihydroxyphenylacetic acid. Olanzapine and lurasidone increased the efflux of acetylcholine; lurasidone increased glutamate as well. None of the compounds significantly altered the efflux of 5‐HT or its metabolite, 5‐hydroxyindole acetic acid, or GABA, serine, and glycine. The ability to increase cortical DA efflux was the only shared effect of the compounds which ameliorates the deficit in cognition in rodents following phencyclidine. <boxed-text content-type="graphic" id="jnc12512-blkfxd-0001" position="anchor" orientation="portrait"><graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgg4sxphzh7" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></boxed-text></p> <p>Abnormalities in dopaminergic, glutamatergic, gamma‐aminobutyric acid (GABAergic), cholinergic, and noradrenergic activity in the medial prefrontal cortex and hippocampus have been implicated in the pathophysiology of the cognitive impairment in schizophrenia. Using <italic>in vivo</italic> microdialysis and UPLC‐MS/MS assay method, the effect of multiple antipsychotics with different binding properties on the efflux of neurotransmitters including acetylcholine (ACh), dopamine (DA), and metabolites, serotonin, serine, glycine, glutamate (Glu) and GABA in the medial prefrontal cortex (mPFC) and nucleus accumbens (NAc) have been studied in rats. Related mechanisms of receptors and neurotransmitter efflux have been discussed.</p> </abstract> … (more)
- Is Part Of:
- Journal of neurochemistry. Volume 128:Number 6(2014:Mar.)
- Journal:
- Journal of neurochemistry
- Issue:
- Volume 128:Number 6(2014:Mar.)
- Issue Display:
- Volume 128, Issue 6 (2014)
- Year:
- 2014
- Volume:
- 128
- Issue:
- 6
- Issue Sort Value:
- 2014-0128-0006-0000
- Page Start:
- 938
- Page End:
- 949
- Publication Date:
- 2013-11-14
- Subjects:
- Neurochemistry -- Periodicals
616.8042 - Journal URLs:
- http://www.blackwell-synergy.com/loi/jnc ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jnc.12512 ↗
- Languages:
- English
- ISSNs:
- 0022-3042
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5021.500000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3484.xml